A Randomized Study of the Safety and Immunogenicity of DTPa-HB-IPV Vaccine Administered as Three Doses or in a Sequential IPV/OPV Schedule at 2, 4, and 6 Months of Age ♦ 933 | Zendy

AI Assistant Blog Pricing

A Randomized Study of the Safety and Immunogenicity of DTPa-HB-IPV Vaccine Administered as Three Doses or in a Sequential IPV/OPV Schedule at 2, 4, and 6 Months of Age ♦ 933

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.